SPRYCEL 50 mg, film-coated tablet 60 tablets
Active ingredients: Dasatinib, Dasatinib monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPRYCEL 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 60 plaquette(s) aluminium de 1 comprimé(s)
- Marketing authorisation holder
- BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Leucémie myéloïde chronique (cancer touchant certaines cellules du sang), chez l'adulte et l'enfant, dans certains cas précisément définis uniquement.<br>- Leucémie aiguë lymphoblastique (cancer touchant certaines cellules du sang), chez l'adulte et l'enfant, dans certains cas précisément définis uniquement. ; JOURNAL OFFICIEL ; 01/11/07
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Nov 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63212461CIP73776416CIP133400937764162Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DASATINIB MONOHYDRATÉcomprimé | — | SA |
| DASATINIBcomprimé | 50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.